TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/2/24 21:00 | 3/30/24 | ROIV | Roivant Sciences Ltd. | D0 | Health | Drug | Pharmaceutical Preparations | Sukhatme Mayukh | X0 | DO | P,Chief | M.d | 0 | 0.00 | 0 | 729 | 16 | 5,310 | D | ||||||||||||||
12/29/23 21:00 | 12/27/23 | ROIV | Roivant Sciences Ltd. | D0 | Health | Drug | Pharmaceutical Preparations | Sukhatme Mayukh | X0 | O | P,Chief | M.d | 0 | 0.00 | 0 | 71 | 1 | 4,947 | D | ||||||||||||||
9/29/23 21:30 | 9/27/23 | ROIV | Roivant Sciences Ltd. | D0 | Health | Drug | Pharmaceutical Preparations | Sukhatme Mayukh | X0 | O | P,Chief | M.d | 0 | 0.00 | 0 | 28 | 1 | 4,875 | D | ||||||||||||||
8/29/23 21:31 | 8/27/23 | ROIV | Roivant Sciences Ltd. | D0 | Health | Drug | Pharmaceutical Preparations | Sukhatme Mayukh | X0 | O | P,Chief | M.d | 0 | 0.00 | 0 | 23 | 0 | 4,848 | D | ||||||||||||||
7/31/23 21:35 | 7/27/23 | ROIV | Roivant Sciences Ltd. | D0 | Health | Drug | Pharmaceutical Preparations | Sukhatme Mayukh | X0 | O | P,Chief | M.d | 0 | 0.00 | 0 | 43 | 1 | 4,825 | D | ||||||||||||||
5/31/23 21:30 | 5/27/23 | ROIV | Roivant Sciences Ltd. | D0 | Health | Drug | Pharmaceutical Preparations | Sukhatme Mayukh | X0 | O | See Rema | M.d | 0 | 0.00 | 0 | 99 | 2 | 4,782 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |